Socioeconomic factors likely contribute to racial and ethnic disparities in health care utilization among patients with ...

New drug delivery technologies, such as nanoparticles, hydrogels, and self-powered microgrippers, are showing great potential ...

Takeda Canada has co-sponsored the Canadian Inflammatory Bowel Disease Research Consortium (CIRC) PIONEER Grant to boost clinical research efforts. The company contributed C$500,000 ($356,932 ...

The overlap of biologics during medication switches is common in routine care of patients with IBD and isn’t linked to a ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

Using vedolizumab first, before tumor necrosis factor-α inhibitors, improved quality-adjusted life-years in both ulcerative ...

IBD is also linked to immune system dysregulation ... but they can highlight high-risk patterns that deserve clinical and research attention," they added. The study was published in the Canadian ...

In April 2025, Janssen Research & Development, LLC announced a study is to evaluate the efficacy, including clinical ...

The biotech had been evaluating the drug, dubbed SZN-043, in a phase 1b trial of ... and a lengthy clinical development path,” the company said in the release. Surrozen stops IBD program due ...